Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 27
1999 45
2000 39
2001 36
2002 51
2003 58
2004 41
2005 46
2006 52
2007 42
2008 36
2009 36
2010 40
2011 112
2012 151
2013 168
2014 209
2015 228
2016 230
2017 208
2018 191
2019 195
2020 55
Text availability
Article attribute
Article type
Publication date

Search Results

1,583 results
Results by year
Filters applied: . Clear all
Page 1
Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images.
Hirasawa T, et al. Gastric Cancer 2018. PMID 29335825
We developed a CNN that can automatically detect gastric cancer in endoscopic images. METHODS: A CNN-based diagnostic system was constructed based on Single Shot MultiBox Detector architecture and trained using 13,584 endoscopic images of gastric cancer. ...The CNN correctly diagnosed 71 of 77 gastric cancer lesions with an overall sensitivity of 92.2%, and 161 non-cancerous lesions were detected as gastric cancer, resulting in a positive predictive value of 30.6%. ...
We developed a CNN that can automatically detect gastric cancer in endoscopic images. METHODS: A CNN-based diagnostic system w …
The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis.
Yue H, et al. Gastric Cancer 2018. PMID 29460004
AIM: To perform a systematic review and meta-analysis to assess the efficacy of the OLGA and OLGIM staging systems in evaluating gastric cancer risk. ...The association between higher stages of gastritis defined by OLGA and risk of gastric cancer was significant. CONCLUSIONS: This correlation implies that close and frequent monitoring of such high-risk patients is necessary to facilitate timely diagnosis of gastric cancer....
AIM: To perform a systematic review and meta-analysis to assess the efficacy of the OLGA and OLGIM staging systems in evaluating gastric
Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001-2007).
Katai H, et al. Gastric Cancer 2018. PMID 28417260
BACKGROUND: The aim of this retrospective study was to investigate the tumor characteristics, surgical details, and survival distribution of surgically resected cases of gastric cancer from the nationwide registry of the Japanese Gastric Cancer Association. ...The proportions of patients with pathological stage (Japanese Gastric Cancer Association) IA, IB, II, IIIA, IIIB, and IV disease were 44.0%, 14.7%, 11.7%, 9.5%, 5.0%, and 12.4% respectively. ...
BACKGROUND: The aim of this retrospective study was to investigate the tumor characteristics, surgical details, and survival distribution of …
Sarcopenia in gastric cancer: when the loss costs too much.
Ongaro E, et al. Gastric Cancer 2017 - Review. PMID 28477106
Malignancy is a major determinant of sarcopenia, and gastric cancer (GC) is among the most common causes of this phenomenon. ...
Malignancy is a major determinant of sarcopenia, and gastric cancer (GC) is among the most common causes of this phenomenon. . …
The therapeutic potential of metformin in gastric cancer.
Courtois S, et al. Gastric Cancer 2019 - Review. PMID 30900101
Thus, since 2005 this molecule is largely studied for its antitumoural properties in different types of cancer. The potential antitumoural effect of metformin in gastric cancer has been poorly studied. Here, we detailed the different described mechanisms implicated in the antitumoural effect of metformin in gastric cancer, from the signalling pathways to the functional effects on gastric cancer cell lines and gastric cancer stem cells....
Thus, since 2005 this molecule is largely studied for its antitumoural properties in different types of cancer. The potential antitum …
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015.
De Manzoni G, et al. Gastric Cancer 2017. PMID 27255288
This article reports the guidelines for gastric cancer staging and treatment developed by the GIRCG, and contains comprehensive indications for clinical management, including radiological, endoscopic, surgical, pathological, and oncological paths....
This article reports the guidelines for gastric cancer staging and treatment developed by the GIRCG, and contains comprehensiv …
Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification.
Yoshida K, et al. Gastric Cancer 2016 - Review. PMID 26643880 Free PMC article.
Conversion therapy for gastric cancer (GC) has been the subject of much recent attention. It is defined as a surgical treatment aiming at an R0 resection after chemotherapy for tumors that were originally unresectable or marginally resectable for technical and/or oncological reasons. ...
Conversion therapy for gastric cancer (GC) has been the subject of much recent attention. It is defined as a surgical treatmen …
Second-line chemotherapy for patients with advanced gastric cancer.
Takahari D. Gastric Cancer 2017 - Review. PMID 28260227
Immune checkpoint inhibitors are now being developed, and the current treatment strategies for advanced gastric cancer may undergo major changes in the future. This review summarizes the transitions and future prospects of clinical developments for second-line therapy in patients with advanced gastric cancer....
Immune checkpoint inhibitors are now being developed, and the current treatment strategies for advanced gastric cancer may und …
1,583 results
Jump to page
Feedback